Keding Enterprises Announces Global Partnership Opportunities in Innovative Building Materials
Seeking entrepreneurs to lead the charge in sustainable construction and design worldwide NEW TAIPEI CITY, Sept. 3, 2024 /PRNewswire/ –
Read More
Author: Bharath
Wriver India Highlights Contemporary Living at Delhi Contemporary Art Week, 2024
Step into a world where artistry meets comfort at Wriver Dialogues, part of Delhi Contemporary Art Week NEW DELHI, Sept.
Read More
Seegene and Springer Nature Launch 'Nature Awards MDx Impact Grants' to Innovate Syndromic PCR Diagnostic Assays
– Nature Awards MDx Impact Grants in partnership with Seegene extends commitment to external innovation.– Global research teams invited to
Read More
ThinkCyte Secures $32 million in Series C Funding to Drive Global Expansion of VisionSort™
TOKYO and REDWOOD CITY, Calif., Aug. 30, 2024 /PRNewswire/ — ThinkCyte today announced the successful completion of its Series C
Read More
Pierre Fabre Laboratories receives European Commission Approval for BRAFTOVI®(encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation
European approval is based on results from the Phase II PHAROS trial, which showed a meaningful clinical benefit to BRAFV600E mutated advanced
Read More
Brand Finance Confirms Yili's Position as World's Most Valuable Dairy Brand for Fifth Consecutive Year
HOHHOT, China, Aug. 30, 2024 /PRNewswire/ — Yili has been recognized as the world’s most valuable dairy brand for the
Read More
PLATINUM EQUITY ACQUIRES CONTROLLING STAKE IN INVENTIA HEALTHCARE
Acquisition of Mumbai-based generic pharmaceutical business led by Platinum’s Asia investment team LOS ANGELES and MUMBAI, India, Aug. 30, 2024 /PRNewswire/
Read More
Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan
BENGALURU, India, Aug. 29, 2024 /PRNewswire/ — Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of
Read More
Shilpa Medicare Makes History: First Indian Company Completes Phase 1 Trial for Recombinant Human Albumin (rHA) 20%
RAICHUR, India, Aug. 28, 2024 /PRNewswire/ — In a major breakthrough, Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) proudly announces the
Read More
Casio to Release Third Signature G-SHOCK with Pro Surfer Kanoa Igarashi
Monochrome Design in Shades of Black and Gray Evokes the Ocean’s Waves, No Two Alike TOKYO, Aug. 28, 2024 /PRNewswire/
Read More